EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

cIMPACT-NOW update 9: Recommendations on utilization of genome-wide DNA methylation profiling for central nervous system tumor diagnostics

Kenneth Aldape iD, David Capper iD, Andreas von Deimling iD, Caterina Giannini iD, Mark R Gilbert iD, Cynthia Hawkins iD, Jürgen Hench iD, Thomas S Jacques iD, David Jones, David N Louis, Sabine Mueller, Brent A Orr iD und 7 weitere

Neuro-Oncology Advances · 06.01.2025 · 7 (1)

DOI: 10.1093/noajnl/vdae228 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Neuro-Oncology Advances, online erschienen am 03.01.2025. Verfasst von Kenneth Aldape und 18 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MarylandUSA. Die Arbeit wurde bisher 43-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Cancer Institute, National Institutes of Health, Brain Tumour Charity.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Genome-wide DNA methylation signatures correlate with and distinguish central nervous system (CNS) tumor types. Since the publication of the initial CNS tumor DNA methylation classifier in 2018, this platform has been increasingly used as a diagnostic tool for CNS tumors, with multiple studies showing the value and utility of DNA methylation-based classification of CNS tumors. A Consortium to Inform Molecular and Practical Approaches to CNS Tumor Taxonomy (cIMPACT-NOW) Working Group was therefore convened to describe the current state of the field and to provide advice based on lessons learned to date. Here, we provide recommendations for the use of DNA methylation-based classification in CNS tumor diagnostics, emphasizing the attributes and limitations of the modality. We emphasize that the methylation classifier is one diagnostic tool to be used alongside previously established diagnostic tools in a fully integrated fashion. In addition, we provide examples of the inclusion of DNA methylation data within the layered diagnostic reporting format endorsed by the World Health Organization (WHO) and the International Collaboration on Cancer Reporting. We emphasize the need for backward compatibility of future platforms to enable accumulated data to be compatible with new versions of the array. Finally, we outline the specific connections between methylation classes and CNS WHO tumor types to aid in the interpretation of classifier results. It is hoped that this update will assist the neuro-oncology community in the interpretation of DNA methylation classifier results to facilitate the accurate diagnosis of CNS tumors and thereby help guide patient management.

Schlagwörter

Stichwörter der Autor:innen

CNS tumorsDNA methylation profilingmolecular classificationneuropathology

Autor:innen und Institutionen

  • Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MarylandUSA.
  • German Cancer Consortium (DKTK), Partner Site Berlin, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Department of Neuropathology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
  • Clinical Cooperation Unit Neuropathology, German Consortium for Translational Cancer Research (DKTK), Deutsches Krebsforschungszentrum (DKFZ), Heidelberg, Germany.
  • Department of Neuropathology, University Hospital Heidelberg, Heidelberg, Germany.
  • Department of Biomedical and Neuromotor Sciences (DIBINEM), Alma Mater Studiorum, Bologna, Italy.

ORCID-Profile: Kenneth Aldape, David Capper, Andreas von Deimling, Caterina Giannini, Mark R Gilbert, Cynthia Hawkins, Jürgen Hench, Thomas S Jacques, Brent A Orr, MacLean Nasrallah, Stefan M Pfister, Felix Sahm, Matija Snuderl, Pascale Varlet

Förderung

  • National Cancer Institute
  • National Institutes of Health
  • Brain Tumour Charity
  • Olivia Hodson Cancer Fund
  • Cancer Research UK
  • National Institute of Health Research

Zitieren

APA

Aldape, K., Capper, D., von Deimling, A., Giannini, C., Gilbert, M. R., Hawkins, C., Hench, J., Jacques, T. S., Jones, D., Louis, D. N., Mueller, S., Orr, B. A., Nasrallah, M., Pfister, S. M., Sahm, F., Snuderl, M., Solomon, D., Varlet, P., & Wesseling, P. (2025). cIMPACT-NOW update 9: Recommendations on utilization of genome-wide DNA methylation profiling for central nervous system tumor diagnostics. Neuro-Oncology Advances, 7(1). https://doi.org/10.1093/noajnl/vdae228

Vancouver

Aldape K, Capper D, von Deimling A, Giannini C, Gilbert MR, Hawkins C, et al. cIMPACT-NOW update 9: Recommendations on utilization of genome-wide DNA methylation profiling for central nervous system tumor diagnostics. Neuro-Oncology Advances. 2025;7(1). doi:10.1093/noajnl/vdae228

BibTeX
@article{Aldape2025,
  author = {Aldape, Kenneth and Capper, David and von Deimling, Andreas and Giannini, Caterina and Gilbert, Mark R and Hawkins, Cynthia and Hench, Jürgen and Jacques, Thomas S and Jones, David and Louis, David N and Mueller, Sabine and Orr, Brent A and Nasrallah, MacLean and Pfister, Stefan M and Sahm, Felix and Snuderl, Matija and Solomon, David and Varlet, Pascale and Wesseling, Pieter},
  title = {cIMPACT-NOW update 9: Recommendations on utilization of genome-wide DNA methylation profiling for central nervous system tumor diagnostics},
  journal = {Neuro-Oncology Advances},
  year = {2025},
  volume = {7},
  number = {1},
  doi = {10.1093/noajnl/vdae228}
}
Kostenlos starten →